BACKGROUND: Valvular heart disease (VHD) has become increasingly common with the aging in China. This study aimed to evaluate regional differences in the clinical features, management strategies, and outcomes of patients with VHD across different regions in China. METHODS: Data were collected from the China-VHD Study. From April 2018 to June 2018, 12,347 patients who presented with moderate or severe native VHD with a median of 2 years of follow-up from 46 centers at certified tertiary hospitals across 31 provinces, autonomous regions, and municipalities in Chinese mainland were included in this study. According to the locations of the research centers, patients were divided into five regional groups: eastern, southern, western, northern, and central China. The clinical features of VHD patients were compared among the five geographical regions. The primary outcome was all-cause mortality or rehospitalization for heart failure. Kaplan-Meier survival analysis was used to compare the cumulative incidence rate. RESULTS: Among the enrolled patients (mean age, 61.96 years; 6877 [55.70%] male), multiple VHD was the most frequent type (4042, 32.74%), which was mainly found in eastern China, followed by isolated mitral regurgitation (3044, 24.65%), which was mainly found in northern China. The etiology of VHD varied significantly across different regions of China. The overall rate of valve interventions was 32.67% (4008/12,268), with the highest rate in southern China at 48.46% (205/423). In terms of procedure, the proportion of transcatheter valve intervention was relatively low compared to that of surgical treatment. Patients with VHD in western China had the highest incidence of all-cause mortality or rehospitalization for heart failure. Valve intervention significantly improved the outcome of patients with VHD in all five regions (all P  <0.05). CONCLUSIONS: This study revealed that patients with VHD in China are characterized by significant geographic disparities in clinical features, treatment, and clinical outcomes. Targeted efforts are needed to improve the management and prognosis of patients with VHD in China according to differences in geographical characteristics. REGISTRATION ClinicalTrials.gov , NCT03484806.
Aged ; Female ; Humans ; Male ; Middle Aged ; China/epidemiology* ; Heart Valve Diseases/therapy* ; Kaplan-Meier Estimate ; Tertiary Care Centers ; Treatment Outcome

With the rapid development of artificial intelligence(AI)technology,its application in the medical field has become increasingly widespread,greatly promoting the innovation and development of the medical industry.However,as the applications of medical AI gradually become popular,they also face ethical challenges closely related to human interests and values,such as the rights and moral responsibilities of medical robots,personal privacy and data security,and fairness.To address the above issues,measures should be taken such as establishing laws and regulations and improving regulatory mechanisms,strengthening technological research and development and preventive measures,involving multiple stakeholders and cross-disciplinary integration,and implementing ethical governance of"responsible innovation".By implementing these strategies,it can promote the sustainable development of medical AI and achieve the harmonious unity of technological innovation and social value

The teaching design of medical humanities English with humanistic spirit as its core makes use of the rain classroom platform to make the important teaching links from pre-class, in-class, and post-class an organic whole, promoting each other. By selecting medical humanities materials, learning English language and various second classes, we can guide students to strengthen their thinking on medical humanities, thus combining humanistic spirit with language skills to improve students' humanistic quality and meet the development needs of higher education in medical colleges.